IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q4 2015 Holdings

Filed 2016-02-16 | 25 holdings | $238.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adamas Pharmaceuticals Inc(ADMSEUR)COM00548A106$40.7K1,437,33517.1%
Five Prime Therapeutics Inc(FPRX)COM33830X104$23.6K569,6589.9%
Zogenix IncCOM NEW98978L204$20.9K1,414,9278.8%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$19.6K2,100,1018.2%
Tetraphase Pharmaceuticals ICOM88165N105$19.5K1,940,0008.2%
Connecture IncCOM20786J106$14.9K4,127,2326.3%
Alcobra LTDSHSM2239P109$12.6K2,012,6225.3%
Exelixis, Inc(EXEL)COM30161Q104$11.5K2,032,4944.8%
Synergy Pharmaceuticals delCOM NEW871639308$8.8K1,546,8883.7%
Sunesis Pharmaceuticals IncCOM NEW867328601$7.4K8,250,0003.1%
GW Pharmaceuticals PLCPutADS36197T103$6.9K100,0002.9%
Paratek Pharmaceuticals IncCOM699374302$6.7K355,4592.8%
Raptor Pharmaceutical CorpCOM75382F106$6.7K1,282,5272.8%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$6.2K2,457,1442.6%
Ocera Therapeutics IncCOM67552A108$6.1K1,963,7772.6%
Bovie Medical CorpCOM10211F100$5.6K2,680,0002.4%
Vericel Corp(VCEL)COM92346J108$5.4K2,086,0282.3%
Aradigm Corp(ARDMEUR)COM NO PAR NEW038505400$4.0K1,002,9621.7%
Tenax Therapeutics IncCOM88032L100$3.6K1,108,5931.5%
Caladrius Biosciences IncCOM128058104$2.4K2,248,7811.0%
Transition Therapeutics IncCOM NEW893716209$1.6K856,6020.7%
Flexion Therapeutics IncCallCALL33938J106$1.5K78,1000.6%
Cytokinetics Inc(CYTK)PutCOM NEW23282W605$1.1K106,8000.5%
Mannkind CorpPutCOM56400P201$729503,0000.3%
Streamline Health SolutionsCOM86323X106$214151,6110.1%